sec document
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
--------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )(1)
MERIT MEDICAL SYSTEMS, INC.
-------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, No Par Value
-------------------------------------------------------------------------------
(Title of Class of Securities)
589889104
-------------------------------------------------------------------------------
(CUSIP Number)
July 18, 2007
-------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
--------------
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ / Rule 13d-1(b)
/x/ Rule 13d-1(c)
/ / Rule 13d-1(d)
--------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, SEE the
NOTES).
---------------------- ----------------------
CUSIP No. 589889104 13G Page 2 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND, LP
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 295,410 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
295,410 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
295,410 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
1.1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 589889104 13G Page 3 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND (OFFSHORE), LTD.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CAYMAN ISLANDS
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 297,027 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
297,027 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
297,027 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
1.1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 589889104 13G Page 4 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND II, LP
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 214,942 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
214,942 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
214,942 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 589889104 13G Page 5 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND II (OFFSHORE), LTD.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CAYMAN ISLANDS
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 427,239 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
427,239 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
427,239 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
1.6%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 589889104 13G Page 6 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND II (QP), LP
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 245,978 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
245,978 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
245,978 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 589889104 13G Page 7 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
CANDENS CAPITAL, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 756,330 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
756,330 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
756,330 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.8%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 589889104 13G Page 8 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER CAPITAL MANAGEMENT, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 724,266 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
724,266 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
724,266 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.7%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 589889104 13G Page 9 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
GABE HOFFMAN
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 1,480,596 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,480,596 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
1,480,596 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.4%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 589889104 13G Page 10 of 17 Pages
---------------------- ----------------------
Item 1(a). Name of Issuer:
Merit Medical Systems, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
1600 West Merit Parkway
South Jordan, Utah 84095
Item 2(a). Name of Person Filing:
This statement is jointly filed by Accipiter Life Sciences Fund, LP,
a Delaware limited partnership ("ALSF"), Accipiter Life Sciences
Fund (Offshore), Ltd., a Cayman Islands company ("Offshore"),
Accipiter Life Sciences Fund II, LP, a Delaware limited partnership
("ALSF II"), Accipiter Life Sciences Fund II (Offshore), Ltd., a
Cayman Islands Company ("Offshore II"), Accipiter Life Sciences Fund
II (QP), LP, a Delaware limited partnership ("QP II"), Accipiter
Capital Management, LLC, a Delaware limited liability company
("Management"), Candens Capital, LLC, a Delaware limited liability
company ("Candens") and Gabe Hoffman (together with ALSF, ALSF II,
Offshore, Offshore II, QP II, Management and Candens, the "Reporting
Person"). Because Gabe Hoffman is the managing member of Candens
(Gabe Hoffman and Candens are hereinafter referred to as the
"Domestic Controlling Persons"), which in turn is the general
partner of ALSF, ALSF II and QP II, and because Gabe Hoffman is the
managing member of Management (Gabe Hoffman and Management are
hereinafter referred to as the "Foreign Controlling Persons"), which
in turn is the investment manager of Offshore and Offshore II, the
Domestic Controlling Persons and Foreign Controlling Persons may be
deemed, pursuant to Rule 13d-3 of the Securities Exchange Act of
1934, as amended (the "Act"), to be the beneficial owners of all
shares of Common Stock held by ALSF, ALSF II, Offshore, Offshore II
and QP II. The Reporting Persons are filing this joint statement, as
they may be considered a "group" under Section 13(d)(3) of the Act.
However, neither the fact of this filing nor anything contained
herein shall be deemed to be an admission by the Reporting Persons
that such a group exists.
Item 2(b). Address of Principal Business Office or, if None, Residence:
399 Park Avenue, 38th Floor
New York, New York 10022
Item 2(c). Citizenship:
ALSF, ALSF II, QP II, Candens and Management are organized under the
laws of the State of Delaware. Offshore and Offshore II are
organized under the laws of the Cayman Islands. Gabe Hoffman is a
citizen of the United States of America.
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
589889104
---------------------- ----------------------
CUSIP No. 589889104 13G Page 11 of 17 Pages
---------------------- ----------------------
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a:
/X/ Not Applicable
(a) / / Broker or dealer registered under Section 15 of the Exchange
Act.
(b) / / Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) / / Insurance company as defined in Section 3(a)(19) of the
Exchange Act.
(d) / / Investment company registered under Section 8 of the Investment
Company Act.
(e) / / An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E).
(f) / / An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F).
(g) / / A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G).
(h) / / A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act.
(i) / / A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act.
(j) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Item 4. Ownership
The percentages reported herein are calculated based on 27,380,754
shares of Common Stock, no par value, outstanding as of May 3, 2007,
as reported in the Issuer's Quarterly Report on Form 10-Q filed with
the Securities and Exchange Commission on May 9, 2007.
See Cover Pages Items 5-11.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following [ ].
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable
---------------------- ----------------------
CUSIP No. 589889104 13G Page 12 of 17 Pages
---------------------- ----------------------
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company or Control Person.
Not Applicable
Item 8. Identification and Classification of Members of the Group.
See Exhibit A.
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certifications.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
---------------------- ----------------------
CUSIP No. 589889104 13G Page 13 of 17 Pages
---------------------- ----------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
Dated: July 20, 2007 ACCIPITER LIFE SCIENCES FUND, LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND II, LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND
(OFFSHORE), LTD.
By: Accipiter Capital Management, LLC
its investment manager
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND II
(OFFSHORE), LTD.
By: Accipiter Capital Management, LLC
its investment manager
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND II (QP),
LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
---------------------- ----------------------
CUSIP No. 589889104 13G Page 14 of 17 Pages
---------------------- ----------------------
ACCIPITER CAPITAL MANAGEMENT, LLC
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
CANDENS CAPITAL, LLC
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
/s/ Gabe Hoffman
---------------------------------------
GABE HOFFMAN
---------------------- ----------------------
CUSIP No. 589889104 13G Page 15 of 17 Pages
---------------------- ----------------------
EXHIBIT INDEX
The following document is filed herewith:
(a) Joint Filing Agreement dated July 20, 2007 among Accipiter
Life Sciences Fund, LP, Accipiter Life Sciences Fund II, LP,
Accipiter Life Sciences Fund (Offshore), Ltd., Accipiter Life
Sciences Fund II (Offshore), Ltd., Accipiter Life Sciences
Fund II (QP), LP, Accipiter Capital Management, LLC, Candens
Capital, LLC and Gabe Hoffman.
---------------------- ----------------------
CUSIP No. 589889104 13G Page 16 of 17 Pages
---------------------- ----------------------
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the Statement on Schedule 13G dated July
__, 2007 with respect to the shares of Common Stock of Merit Medical Systems,
Inc. and any further amendments thereto executed by each and any of the
undersigned shall be filed on behalf of each of the undersigned pursuant to and
in accordance with the provisions of Rule 13d-1(k)(1) under the Securities
Exchange Act of 1934, as amended.
Dated: July 20, 2007 ACCIPITER LIFE SCIENCES FUND, LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND II, LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND
(OFFSHORE), LTD.
By: Accipiter Capital Management, LLC
its investment manager
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND II
(OFFSHORE), LTD.
By: Accipiter Capital Management, LLC
its investment manager
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
---------------------- ----------------------
CUSIP No. 589889104 13G Page 17 of 17 Pages
---------------------- ----------------------
ACCIPITER LIFE SCIENCES FUND II (QP),
LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER CAPITAL MANAGEMENT, LLC
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
CANDENS CAPITAL, LLC
By: /s/ Gabe Hoffman
----------------------------------
Gabe Hoffman, Managing Member
/s/ Gabe Hoffman
---------------------------------------
GABE HOFFMAN